Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Jean DaSilva; Clemens Decristoforo; Robert H Mach; Guy Bormans; Giuseppe Carlucci; Mohammed Al-Qahtani; Adriano Duatti; Antony D Gee; Wiktor Szymanski; Sietske Rubow; Jeroen Hendrikx; Xing Yang; Hongmei Jia; Junbo Zhang; Peter Caravan; Hua Yang; Jan Rijn Zeevaart; Miguel Avila Rodriquez; Ralph Santos Oliveira; Marcela Zubillaga; Tamer Sakr; Sarah Spreckelmeyer

doi:10.1186/s41181-023-00218-y

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

EJNMMI Radiopharm Chem. 2023 Oct 27;8(1):35. doi: 10.1186/s41181-023-00218-y.

Authors

Jean DaSilva¹, Clemens Decristoforo², Robert H Mach³, Guy Bormans⁴, Giuseppe Carlucci⁵, Mohammed Al-Qahtani⁶, Adriano Duatti⁷, Antony D Gee⁸, Wiktor Szymanski⁹, Sietske Rubow¹⁰, Jeroen Hendrikx¹¹, Xing Yang¹², Hongmei Jia¹³, Junbo Zhang¹³, Peter Caravan¹⁴, Hua Yang¹⁵, Jan Rijn Zeevaart¹⁶, Miguel Avila Rodriquez¹⁷, Ralph Santos Oliveira¹⁸, Marcela Zubillaga¹⁹, Tamer Sakr²⁰, Sarah Spreckelmeyer²¹

Affiliations

¹ University of Montreal, Montreal, Canada.
² Medical University Innsbruck, Innsbruck, Austria.
³ University of Pennsylvania, Philadelphia, USA.
⁴ University of Leuven, Leuven, Belgium.
⁵ UCLA, Los Angeles, USA.
⁶ King Faisal Specialist Hospital and Research Center, Riad, Saudi Arabia.
⁷ University of Ferrara, Ferrara, Italy.
⁸ King's College, London, UK.
⁹ University of Groningen, Groningen, The Netherlands.
¹⁰ Stellenbosch University, Stellenbosch, South Africa.
¹¹ NKI, Amsterdam, The Netherlands.
¹² Peking University First Hospital, Beijing, China.
¹³ Beijing Normal University, Beijing, China.
¹⁴ Massuchusetts General Hospital, Harvard University, Boston, USA.
¹⁵ TRIUMF, Vancouver, Canada.
¹⁶ Necsa, Pretoria, South Africa.
¹⁷ Universidad Nacional Autonoma de Mexico (UNAM), Mexico-City, Mexico.
¹⁸ Brazilian Association of Radiopharmacy Brazil, Brazilian Nuclear Energy Commission - Nuclear Engineering Institute, State University of Rio de Janeiro, Rio de Janeiro, Brazil.
¹⁹ University of Buenos Aires, Buenos Aires, Argentina.
²⁰ Egyptian Atomic Energy Authority, Cairo, Egypt.
²¹ Department of Nuclear Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany. sarah.spreckelmeyer@charite.de.

Abstract

Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.

Main body: This selection of highlights provides commentary on 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.

Conclusion: Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.

Keywords: Highlight articles; Nuclear medicine; Radiochemistry; Radiopharmaceutical sciences; Radiopharmacy; Trends in radiopharmaceutical sciences.

Publication types

Review